Therefore, we studied the relationship between the plasma EV-derived MARCKSL1 level and the tumor stage and clinicopathological markers of CRC in healthy people, patients with nonmetastatic CRC and colorectal cancer to assess its value in the early diagnosis of CRC progression. The gene discussed is MARCKSL1; the disease is neoplasm.